U.S. warns of muscle harm when heart drugs combined

                   
reuters.co.uk     08-Aug-2008            

WASHINGTON (Reuters) - U.S. health officials warned the public on Friday about the risk of a rare type of muscle injury seen when the cholesterol drug simvastatin is combined with the anti-arrhythmia medicine amiodarone. The Food and Drug Administration said it continued to receive reports of rhabdomyolysis, a type of muscle injury that can lead to kidney failure or death, despite a 2002 warning about combining the drugs. Simvastatin is an ingredient in Merck & Co's Zocor and Abbott Laboratories Inc's Simcor, and is sold generically. It also is one of two components in Merck and Schering-Plough Corp's Vytorin. Amiodarone is an ingredient in Wyeth's Cordarone and is also sold generically. (Reporting by Lisa Richwine, editing by Gerald E.... [read full story]                    

Full Coverage
                   

FDA warns of muscle harm when heart drugs combined

reuters.co.uk     08-Aug-2008          

WASHINGTON (Reuters) - U.S. health officials warned the public on Friday about the risk of a rare type of muscle injury seen when the cholesterol drug simvastatin is combined with the anti-arrhythmia medicine amiodarone.                    

comments

                   

U.S. warns of muscle damage when heart drugs combined

reuters.co.uk     08-Aug-2008          

WASHINGTON (Reuters) - U.S. health officials warned the public on Friday about the risk of a rare type of muscle injury seen when the cholesterol drug simvastatin is combined with the anti-arrhythmia medicine amiodarone.                    

comments

                   

FDA Issues Alert On Drugs' Link To Muscle Injury

pharmiweb.co.uk     09-Aug-2008          

Word Count: 312 | Companies Featured in This Article: Merck, Schering-Plough, Abbott Laboratories, Wyeth, Pfizer WASHINGTON -- Federal regulators continue to receive reports of muscle injury in patients taking a combination of...                    

comments

                   

FDA: Drugs Linked to Muscle Injury

pharmiweb.co.uk     11-Aug-2008          

Word Count: 312 | Companies Featured in This Article: Merck, Schering-Plough, Abbott Laboratories, Wyeth, Pfizer WASHINGTON -- Federal regulators continue to receive reports of muscle injury in patients taking a combination of...                    

comments

                   

FDA Warns Of Muscle Damage When Cholesterol Drug Combined With Anti-Arrhythmia Drug

pharmiweb.co.uk     11-Aug-2008          

August 11, 2008 (FinancialWire) The Food and Drug Administration has warned the public about the risk of a rare type of muscle injury seen when the cholesterol drug simvastatin is combined with the anti-arrhythmia drug...                    

comments